Increasing public awareness of foodborne illnesses, factory farming, and the ecological
footprint of the meat industry, has generated the need for animal-free meat alternatives. In …

Cancer is the second leading cause of death worldwide, and it is estimated that Human
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …

Although plant biotechnology has been widely investigated for the production of clinical‐
grade monoclonal antibodies, no antibody products derived from transgenic plants have yet …

Plant-derived protein research has gained attention in recent years due to the rise of health
concerns, allergenicity, trends toward vegan diet, food safety, and sustainability; but the …

Plants offer fast, flexible and easily scalable alternative platforms for the production of
pharmaceutical proteins, but differences between plant and mammalian N‐linked glycans …

Plants have had numerous biological, clinical, pharmaceutical and medicinal purposes for
many years; however, their use as a general platform for preparation of desired …

Plant-based biomanufacturing of therapeutic proteins is a relatively new platform with a
small number of commercial-scale facilities, but offers advantages of linear scalability …

Vaccines are recognized worldwide as one of the most important tools for combating
infectious diseases. Despite the tremendous value conferred by currently available vaccines …

Biopharmaceuticals are a large and fast-growing sector of the total pharmaceutical market
with antibody-based therapeutics accounting for over 100 billion USD in sales yearly …

Although the plant‐made vaccine field started three decades ago with the promise of
developing low‐cost vaccines to prevent infectious disease outbreaks and epidemics …